Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

PURPOSE: Cardiac involvement predicts poor prognosis in light chain (AL) amyloidosis, and the current prognostic classification is based on cardiac biomarkers troponin-T (cTnT) and N-terminal pro–B-type natriuretic peptide (NT-ProBNP). However, long-term outcome is dependent on the underlying plasma...

Full description

Saved in:
Bibliographic Details
Main Authors: Kumar, Shaji, Dispenzieri, Angela, Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Colby, Colin, Laumann, Kristina, Zeldenrust, Steve R., Leung, Nelson, Dingli, David, Greipp, Philip R., Lust, John A., Russell, Stephen J., Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2012
Subjects:
Original Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3675680/
https://ncbi.nlm.nih.gov/pubmed/22331953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.5724
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items